Skip to main content
HOUSE 934115th CongressReferred to the Subcommittee on Health.

Personal Drug Importation Fairness Act of 2017

Last Action
2/10/2017

Actions

  • 2017-02-10Referred to the Subcommittee on Health.
  • 2017-02-07Referred to the House Committee on Energy and Commerce.
  • 2017-02-07Introduced in House
  • 2017-02-07Introduced in House

CRS Summary

As of 2017-02-07 (00)

Personal Drug Importation Fairness Act of 2017

This bill allows a drug to be imported by a person other than the drug's manufacturer if the drug: (1) has the same active ingredients, route of administration, and strength as an approved drug; (2) may be lawfully marketed in, and is imported or reimported from, a country included on a list in this Act that the Food and Drug Administration determines has standards for ensuring drug safety and effectiveness that are at least as protective as U.S. standards; (3) is dispensed by a licensed pharmacist; (4) is shipped directly to, or is imported by, the ultimate consumer; (5) is shipped or imported in quantities that do not exceed a 90-day supply; (6) is accompanied by a copy of a valid prescription; and (7) is not a controlled substance.

Cosponsors (1)

  • DANA ROHRABACHER (R-CA)

Subjects

  • Africa
  • Asia
  • Australia
  • Canada
  • Drug safety, medical device, and laboratory regulation
  • Europe
  • European Union
  • Israel
  • Japan
  • New Zealand
  • Oceania
  • Prescription drugs
  • South Africa
  • Switzerland
  • Trade restrictions
Read on Congress.gov

Sourced from Congress.gov (public domain).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.